This dual activation enhances the immunostimulatory milieu, as seen in reduced tumor proliferation (via Ki67 staining) and increased cytokine production (e.g., CCL5, CXCL10, TNFα) in syngeneic models. This evidence concerns the gene TNF and neoplasm.